These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 1342043)
1. Does melatonin mediate the therapeutic effects of 5-HT reuptake inhibitors in obsessive compulsive disorder? Sandyk R Int J Neurosci; 1992; 64(1-4):221-3. PubMed ID: 1342043 [No Abstract] [Full Text] [Related]
2. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder. Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069 [TBL] [Abstract][Full Text] [Related]
3. The pathogenesis and treatment of obsessive-compulsive disorder. Dolberg OT; Iancu I; Sasson Y; Zohar J Clin Neuropharmacol; 1996 Apr; 19(2):129-47. PubMed ID: 8777767 [TBL] [Abstract][Full Text] [Related]
4. The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity. Brakoulias V Expert Opin Pharmacother; 2014 Jul; 15(10):1321-3. PubMed ID: 24866422 [TBL] [Abstract][Full Text] [Related]
6. Using graph theory to connect the dots in obsessive-compulsive disorder. Taylor SF Biol Psychiatry; 2014 Apr; 75(8):593-4. PubMed ID: 24673774 [No Abstract] [Full Text] [Related]
7. Efficacy of clomipramine in obsessive-compulsive disorder. Howland RH Anxiety; 1996; 2(1):56-7. PubMed ID: 9160602 [No Abstract] [Full Text] [Related]
8. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Pigott TA; Seay SM J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636 [TBL] [Abstract][Full Text] [Related]
9. Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder. Humble M; Bejerot S; Bergqvist PB; Bengtsson F Biol Psychiatry; 2001 Feb; 49(4):360-8. PubMed ID: 11239907 [TBL] [Abstract][Full Text] [Related]
10. Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment. Monteleone P; Catapano F; Tortorella A; Di Martino S; Maj M Psychoneuroendocrinology; 1995; 20(7):763-70. PubMed ID: 8848522 [TBL] [Abstract][Full Text] [Related]
12. A longitudinal event-related potential study of selective serotonin reuptake inhibitor therapy in treatment-naïve pediatric obsessive compulsive disorder patients. Yamamuro K; Ota T; Iida J; Kishimoto N; Nakanishi Y; Matsuura H; Uratani M; Okazaki K; Kishimoto T Psychiatry Res; 2016 Nov; 245():217-223. PubMed ID: 27552672 [TBL] [Abstract][Full Text] [Related]
13. Venlafaxine for treatment of obsessive-compulsive disorder. Ananth J; Burgoyne K; Smith M; Swartz R Am J Psychiatry; 1995 Dec; 152(12):1832. PubMed ID: 8526258 [No Abstract] [Full Text] [Related]